How does re-classification of variants of unknown significance (VUS) impact the management of patien...
How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The popularity of multigene testing increases the probability of identifying variants of uncertain significance (VUS). While accurate variant interpretation enables clinicians to be better informed of the genetic risk of their patients, currently, there is a lack of consensus management guidelines for clinicians on VUS.
Among the BRCA1 and BRCA2...
Alternative Titles
Full title
How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7783bc06d4f8473ebd28c6a2080cce23
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7783bc06d4f8473ebd28c6a2080cce23
Other Identifiers
ISSN
1755-8794
E-ISSN
1755-8794
DOI
10.1186/s12920-022-01270-4
